For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...
NewsNation on MSN
Experimental Alzheimer’s drug could prevent disease early
The experimental drug, NU-9, targets toxic proteins that may trigger Alzheimer’s decades before memory loss begins. In mice, ...
After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...
Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...
The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...
Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...
A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...
About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...
Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...
3dOpinion
Medicare covers blood tests for cancer and diabetes, so why not Alzheimer’s? | PennLive letters
A new bipartisan bill would end the coverage gap for dementia screening, allowing early diagnosis when treatments are most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback